Universal Cells

Universal Cells

Biotechnology, 3005 1st Ave, Seattle, Washington, 98121, United States, 11-50 Employees

universalcells.com

  • LinkedIn

phone no Phone Number: +12*********

Who is UNIVERSAL CELLS

Universal Cells Inc. is a private biotechnology company based in Seattle, Washington that is enabling the field of regenerative medicine by creating stem cells that are universally compat...

Read More

map
  • 3005 1st Ave, Seattle, Washington, 98121, United States Headquarters: 3005 1st Ave, Seattle, Washington, 98121, United States
  • 2013 Date Founded: 2013
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541720 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from UNIVERSAL CELLS

Universal Cells Org Chart and Mapping

Employees

Mustafa Tuncali

Principal Research Associate

Neha Hatangadi

Senior Research Associate

Lea Ono

Senior Reseach Associate

Lisa Petek

Senior Director of Core Technologies

Nick Du

Associate Director Project Management

David Fine

Sr. Research Associate

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Universal Cells

Answer: Universal Cells's headquarters are located at 3005 1st Ave, Seattle, Washington, 98121, United States

Answer: Universal Cells's phone number is +12*********

Answer: Universal Cells's official website is https://universalcells.com

Answer: Universal Cells's revenue is $25 Million to $50 Million

Answer: Universal Cells's SIC: 8731

Answer: Universal Cells's NAICS: 541720

Answer: Universal Cells has 11-50 employees

Answer: Universal Cells is in Biotechnology

Answer: Universal Cells contact info: Phone number: +12********* Website: https://universalcells.com

Answer: Universal Cells Inc. is a private biotechnology company based in Seattle, Washington that is enabling the field of regenerative medicine by creating stem cells that are universally compatible. Our technology is based on intellectual property exclusively in-licensed from the University of Washington and includes methods for genome editing in human stem cells via homologous recombination with recombinant adeno-associated virus (rAAV) vectors, as well as specific HLA-engineering strategies.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access